Effect of an 8-month treatment with ω-3 fatty acids (eicosapentaenoic and docosahexaenoic) in patients with cystic fibrosis

Journal of Parenteral and Enteral Nutrition

Volumn 27, Issue 1, 2003, Pages 52-57

  De Vizia, Basilio ^a,c   Raia, Valeria ^a   Spano, Christian ^b   Pavlidis, Christiane ^a   Coruzzo, Anna ^a   Alessio, Mariolina ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b ALF X Surgical Robotics Department   (Italy)

^c Department of Pediatrics ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; ANTIBIOTIC AGENT; ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; FATTY ACID; FISH OIL; ICOSAPENTAENOIC ACID; IMMUNOGLOBULIN G; LINOLEIC ACID; MEMBRANE PHOSPHOLIPID; OMEGA 3 FATTY ACID; TRIOLIP;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CALORIC INTAKE; CLINICAL ARTICLE; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTIC FIBROSIS; DIET SUPPLEMENTATION; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG SCREENING; ERYTHROCYTE MEMBRANE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LUNG FUNCTION TEST; MALE; PNEUMONIA; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 0037242749     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/014860710302700152     Document Type: Article

References (46)

1. Martin TR, Pistorese BP, Chi EY, et al: Effect of leukotrieneB4 in the human lung. Recruitment of neutrophils into alveolar space without change in protein permeability. J Clin Invest 84:1609-1619, 1989
2. Ming WJI, Bersani L, Mantovani A: Tumor necrosis factor is chemotactic for monocytes and polymorphonuclear leucocytes. J Immunol 138:1469-1474, 1987
3. Martin TR, Altman LC, Albert RK, et al: Leukotriene B4 production by alveolar macrophages: A potential mechanism for amplifying inflammation in the lung. Am Rev Respir Dis 129:106-111, 1984
4. Zakrzewisky JT, Barnes NC, Costello JF, et al: Detection of sputum eicosanoids in cystic fibrosis and in normal saliva by bioassays and radioimmunoassay. Br J Clin Pharmacol 23:19-27, 1987
5. Konstan MW, Walenga RW, Hilliard KA, et al: Leukotriene B4 markedly elevated in the epithelial lining fluid if patients with cystic fibrosis. Am Rev Respir Dis 148:896-901, 1993
6. Sampson AP, Spencer DA, Green CP, et al: Leukotriene in the sputum and urine of cystic fibrosis children. Br J Clin Pharmacol 30:861-869, 1990
7. Suter S, Schaad UB, Roux-Lmbard P, et al: Relation between tumor necrosis factor-alpha and granulocyte elastase-1 proteinase inhibitor complexes in the plasma of patients with cystic fibrosis. Am Rev Respir Dis 140:1640-1644, 1989
8. Elborn JS, Norman D, Delamere FM, et al: In vitro tumor necrosis-secretion by monocytes from patient with cystic fibrosis. Am J Respir Cell Mol Biol 6:207-211, 1992
9. Greally P, Hussein MJ, Cook AJ, et al: Sputum tumor necrosis factor-alpha and leukotriene concentration in cystic fibrosis. Arch Dis Child 63:389-392, 1993
10. Kronborg G, Hansen MB, Svenson M, et al: Cytokines in sputum and serum from patients with cystic fibrosis and chronic pseudomonas aeruginosa infection as markers of destructive inflammation in the lung. Pediatr Pulmonol 15:292-297, 1993
11. Gurg ML, Sebokova E, Thomson ABR, et al: Effect of dietary cholesterol and/or w3 fatty acid on lipid composition and Δ-5 saturase activity of rat liver microsomes. J Nutr 118:661-668, 1988
12. Prescott SM: The effect of eicosapentaenoic acid on the leukotriene B production by human neutrophils. J Biol Chem 259:615-621, 1984
13. Keicher U, Koletzko B, Reinnardt D: ω-3 fatty acids suppress the enhanced production of 5-lipoxygenase products from polymorph neutrophil granulocytes in cystic fibrosis. Eur J Clin Invest 25:915-919, 1995
14. Lee TH, Hoover RL, William JD, et al: Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acid on in vitro neutrophils and monocyte leukotriene generation and neutrophil function. N Engl J Med 312:1217-1224, 1985
15. Lee TH, Mencia-Huerta J-M, Shih C, et al: Effects of exogenous arachidonic, eicosapentaenoic, docosahexaenoic on generation of 5-lipoxygenase pathways products by ionophore-activated human neutrophils. J Clin Invest 74:1922-1933, 1984
16. Lee TH, Mencia-Huerta J-M, Shih C, et al: Characterization and biologic properties of 5,12 dihydroxy derivatives of eicosapentaenoic acid, including leukotriene B5 and double lipoxygenase product. J Biol Chem 259:2383-2389, 1984
17. Andres S, Ghorbani R, Kelly VE, et al: The effect of dietary supplementation with n-3 polyunsaturated fatty acids on synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 320:265-271, 1989
18. Belluzzi A, Brignola C, Campieri M, et al: Effect of coated fish-oil preparation on relapse in Crohn's disease. N Engl J Med 334: 1557-1560, 1996
19. Henderson WR, Astley SJ, McCready SJ, et al: Oral absorption of ω-3 fatty acids in patients with cystic fibrosis who have pancreatic insufficiency and in healthy control subjects. J Pediatr 124:400-408, 1994
20. Kurlandsky LE, Bennink MR, Phyllis MW, et al: The absorption and effect of dietary supplementation with ω-3 fatty acids on serum leukotriene B4 in patients with cystic fibrosis. Pediatr Pulmonol 18:211-217, 1984
21. Katz DP, Manner T, Furst P, et al: The use of intravenous fish oil emulsion enriched with ω-3 fatty acids in patients with cystic fibrosis. Nutrition 12:334-339, 1966
22. Lawrence R, Sorrell T: Eicosapentaenoic acid in cystic fibrosis: Evidence of pathogenetic role for leukotriene B4. Lancet 34:465-469, 1993
23. Thies NH: The effect of 12 months' treatment with eicosapentaenoic acid in five children with cystic fibrosis. J Pediatr Child Health 33:349-351, 1997
24. -/- mice. Proc Natl Acad Sci USA 96:13995-14000, 1999
25. Kang J, Brown N, Man SFP, et al: The chloride channel blocker anthracene inhibit fatty acid incorporation into phospholipid in cultured human airway epithelial cells. Biochem J 285:725-729, 1992
26. Gilljam H, Strandvik B, Ellin A, et al: Increased mole fraction of arachidonic acid in bronchial phospholipids in patients with cystic fibrosis. Scand J Lab Invest 46:511-518, 1986
27. Dodge JT, Mitchell DJ: The preparation and chemical characteristic of hemoglobin-free ghost of human erythrocytes. Arch Biochem Biophys 100:119-130, 1963
28. Folch J, Lees M, Sloane Stanley GH, et al: A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226:497-509, 1957
29. Stoffel W, Chu F, Ahrens H Jr: Analysis of long-chain fatty acids by gas-liquid chromatography. Anal Chem 31:307-311, 1959
30. Lloyd-Still JD, Johnson SB, Holman RT: Essential fatty acid status in cystic fibrosis and the effects of safflower oil supplementation. Am J Clin Nutr 34:1-7, 1981
31. Benabdeslam H, Garcia I, Bellon G, et al: A. Biochemical assessment of the nutritional status of cystic fibrosis patients treated with pancreatic extracts. Am J Clin Nutr 67:912-918, 1997
32. Roulet M, Frascarolo P, Rappaz J, et al: Essential fatty acid deficiency in well nourished young cystic fibrosis patients. Eur J Pediatr 156:952-956, 1997
33. Clandinin MT, Zuberhbuler P, Brown NE, et al: Fatty acid pool size in plasma lipoprotein fractions of cystic fibrosis patients. Am J Clin Nutr 62:1268-1275, 1995
34. Chase PH, Dupont J: Abnormal levels of prostaglandins and fatty acids in blood of children with cystic fibrosis. Lancet 2:236-238, 1978
35. Brown AJ, Pang E, Roberts DCK: Persistent changes in the fatty acid composition of erythrocyte membranes after moderate intake of n-3 polyunsaturated fatty acids: Study design implications. Am J Clin Nutr 54:668-673, 1991
36. Baur LA, O'Connor J, Wu BJ, et al: Relationship between the fatty acid composition of muscle and erythrocyte membrane phospholipid in young children and the effect of type of infant feeding. Lipids 35:77-82, 1998
37. Hubbard VS, McKenna MC: Absorption of safflower oil and structured lipid preparation in patients with cystic fibrosis. Lipids 22:424-428, 1987
38. Stead RJ, Barradas MA, Mikhailidis DP, et al: Platelets function in patients with cystic fibrosis. Prog Lipid Res 25:305-307, 1986
39. Mathias MM, Dupont J: Quantitative relationships between dietary linoleate and prostaglandin (eicosanoids) biosynthesis. Lipids 20:791-801, 1985
40. Horrobin DF, Manku MS, Huang YS, et al: Effects of essential fatty acids on prostaglandin biosynthesis. Biomed Biochim Acta 43:S114-S118, 1984
41. Levistre R, Lemnauar M, Rybkinr T, et al: Increase of bradykinin-stimulated arachidonic acid release in a delta 508 cystic fibrosis epithelial line. Biochim Biophys Acta 1181:233-239, 1993
42. Berguerand M, Klapisz E, Thomas G, et al: Differential stimulation of cytosolic phospholipase A-2 by bradykinin in human cystic fibrosis cell lines. Am J Respir Cell Mol Biol 17:481-490, 1997
43. Cromwell O, Morris HR, Hodson ME, et al: Identification of leukotrienes D and B in sputum from cystic fibrosis patients. Lancet 2:164-165, 1981
44. Von Schacky C, Fischer S, Weber PC: Long-term effects of dietary marine ω-3 fatty acids upon plasma and cellular lipids, platelet function, and eicosanoid formation in humans. J Clin Invest 76:1626-1631, 1985
45. Harris WS: Fish oil and plasma lipid and lipoprotein metabolism in human: A critical review. J Lipid Res 30:785-807, 1980
46. Von Schacky C, Weber PC: Metabolism and effect on platelet function of the purified eicosapentaenoic and docosahexaenoic acids in humans. J Clin Invest 76:2446-2450, 1985